Blood test clues: could two proteins predict heart failure after a heart attack?

NCT ID NCT00762333

NEW Recruiting now Knowledge-focused Sponsor: UConn Health Source: ClinicalTrials.gov ↗

First seen Aug 17, 2026 · Last updated Aug 17, 2026

Summary

This study looks at whether two proteins released when heart muscle is damaged can be detected in the blood during a heart attack. Researchers want to see if higher levels of these proteins are linked to a greater chance of developing heart failure afterward. The study includes adults who have had a heart attack, with or without heart failure, and a control group for comparison. By measuring these proteins, the study aims to uncover potential markers that might one day help guide patient care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If these proteins prove to be reliable markers, they could help identify heart attack patients at higher risk of developing heart failure, guiding earlier or more intensive treatment.
What could go wrong: This is an observational study, so it cannot prove cause and effect. The proteins may not consistently predict heart failure, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction congestive heart failure heart failure ischemic disease myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONGESTIVE HEART FAILURE ISCHEMIA MYOCARDIAL INFARCTION

Contacts and locations

Locations

University of Connecticut Health Center
RECRUITING

Farmington, Connecticut, 06030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.